Cargando…
More Adventures in Photodynamic Therapy
Photodynamic therapy is a procedure that can provide a selective eradication of neoplastic disease if sufficient drug, light, and oxygen are available. As this description suggests, it involves the photosensitization of malignant tissues to irradiation with photons in the visible range. While not su...
Autor principal: | |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4519894/ https://www.ncbi.nlm.nih.gov/pubmed/26151850 http://dx.doi.org/10.3390/ijms160715188 |
_version_ | 1782383573214429184 |
---|---|
author | Kessel, David |
author_facet | Kessel, David |
author_sort | Kessel, David |
collection | PubMed |
description | Photodynamic therapy is a procedure that can provide a selective eradication of neoplastic disease if sufficient drug, light, and oxygen are available. As this description suggests, it involves the photosensitization of malignant tissues to irradiation with photons in the visible range. While not suitable for tumors at unknown loci, it can be of use for eradication of cancer at surgical margins and therapy at sites where substantial surgery might otherwise be involved. Drug development has been delayed by several factors including the reluctance of major pharmaceutical firms in the United States to invest in this technology along with some unwise approaches in the past. |
format | Online Article Text |
id | pubmed-4519894 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2015 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-45198942015-08-03 More Adventures in Photodynamic Therapy Kessel, David Int J Mol Sci Commentary Photodynamic therapy is a procedure that can provide a selective eradication of neoplastic disease if sufficient drug, light, and oxygen are available. As this description suggests, it involves the photosensitization of malignant tissues to irradiation with photons in the visible range. While not suitable for tumors at unknown loci, it can be of use for eradication of cancer at surgical margins and therapy at sites where substantial surgery might otherwise be involved. Drug development has been delayed by several factors including the reluctance of major pharmaceutical firms in the United States to invest in this technology along with some unwise approaches in the past. MDPI 2015-07-03 /pmc/articles/PMC4519894/ /pubmed/26151850 http://dx.doi.org/10.3390/ijms160715188 Text en © 2015 by the authors; licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Commentary Kessel, David More Adventures in Photodynamic Therapy |
title | More Adventures in Photodynamic Therapy |
title_full | More Adventures in Photodynamic Therapy |
title_fullStr | More Adventures in Photodynamic Therapy |
title_full_unstemmed | More Adventures in Photodynamic Therapy |
title_short | More Adventures in Photodynamic Therapy |
title_sort | more adventures in photodynamic therapy |
topic | Commentary |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4519894/ https://www.ncbi.nlm.nih.gov/pubmed/26151850 http://dx.doi.org/10.3390/ijms160715188 |
work_keys_str_mv | AT kesseldavid moreadventuresinphotodynamictherapy |